Freshfields Bruckhaus Deringer advised Affimed N.V. (Nasdaq: AFMD) on the deal. Affimed N.V. announced its strategic collaboration with Artiva Biotherapeutics Inc. (‘Artiva‘), likewise an immuno-oncology company, to jointly...
Affimed N.V.’s Cooperation With Artiva Biotherapeutics
Moderna’s Ten-Year Agreement With Monash University and the State of Victoria to Produce mRNA Vaccines
Freshfields Advised Moderna on the deal. Moderna completed its ten-year agreement with the State of Victoria to establish a state-of-the-art, domestic mRNA vaccine manufacturing facility at...